Tokyo Tape
Sign in
← Kaken Pharmaceutical

Half-year report · Q2

4521.TEDINET S100UP1J
Period2024-04-01 → 2024-09-30
Filed2024-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥51.4bn2024-04-01 → 2024-09-30Cons.Net sales
Revenue¥72.0bn2023-04-01 → 2024-03-31Cons.Net sales (5-year summary)
Revenue¥36.2bn2023-04-01 → 2023-09-30Cons.Net sales
Operating income¥19.6bn2024-04-01 → 2024-09-30Cons.Operating income
Operating income¥5.5bn2023-04-01 → 2023-09-30Cons.Operating income
Ordinary income¥19.8bn2024-04-01 → 2024-09-30Cons.Ordinary income
Ordinary income¥10.0bn2023-04-01 → 2024-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥5.7bn2023-04-01 → 2023-09-30Cons.Ordinary income
Profit before tax¥19.2bn2024-04-01 → 2024-09-30Cons.Income before income taxes
Profit before tax¥5.7bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)¥14.3bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥8.0bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥4.1bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income¥14.3bn2024-04-01 → 2024-09-30Cons.Profit loss
Net income¥4.1bn2023-04-01 → 2023-09-30Cons.Profit loss
Total assets¥187.1bnat 2024-09-30Cons.Assets
Total assets¥171.6bnat 2024-03-31Cons.Assets
Total assets¥171.7bnat 2023-09-30Cons.Total assets (5-year summary)
Total liabilities¥32.7bnat 2024-09-30Cons.Liabilities
Total liabilities¥27.9bnat 2024-03-31Cons.Liabilities
Net assets / equity¥154.4bnat 2024-09-30Cons.Net assets
Net assets / equity¥143.8bnat 2024-03-31Cons.Net assets
Net assets / equity¥140.7bnat 2023-09-30Cons.Net assets (5-year summary)
Cash and deposits¥67.3bnat 2024-09-30Cons.Cash and deposits
Cash and deposits¥50.6bnat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥84.0bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥65.3bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥70.1bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥74.3bnat 2023-03-31dCons.Cash and cash equivalents
Operating cash flow¥23.9bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥2.6bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥245m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥2.4bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥5.9bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.1bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥2.8bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥5.7bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥2.8bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥377.232024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥212.672023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥108.182023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio82.5%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio83.8%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio82.0%at 2023-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q2r_E00935-000Medicinereportable segmentrevenue2024-04-01 → 2024-09-30¥50.1bn
jpcrp040300-q2r_E00935-000Medicinereportable segmentrevenue external2024-04-01 → 2024-09-30¥50.1bn
jpcrp040300-q2r_E00935-000Medicinereportable segmentsegment profit2024-04-01 → 2024-09-30¥18.9bn
jpcrp040300-q2r_E00935-000Real Estatereportable segmentrevenue2024-04-01 → 2024-09-30¥1.2bn
jpcrp040300-q2r_E00935-000Real Estatereportable segmentrevenue external2024-04-01 → 2024-09-30¥1.2bn
jpcrp040300-q2r_E00935-000Real Estatereportable segmentsegment profit2024-04-01 → 2024-09-30¥676m
Total Of Reportable Segments And Otherssegment totalrevenue2024-04-01 → 2024-09-30¥51.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-04-01 → 2024-09-30¥51.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2024-04-01 → 2024-09-30¥19.6bn
jpcrp040300-q2r_E00935-000Medicinereportable segmentrevenue2023-04-01 → 2023-09-30¥35.0bn
jpcrp040300-q2r_E00935-000Medicinereportable segmentrevenue external2023-04-01 → 2023-09-30¥35.0bn
jpcrp040300-q2r_E00935-000Medicinereportable segmentsegment profit2023-04-01 → 2023-09-30¥4.9bn
jpcrp040300-q2r_E00935-000Real Estatereportable segmentrevenue2023-04-01 → 2023-09-30¥1.2bn
jpcrp040300-q2r_E00935-000Real Estatereportable segmentrevenue external2023-04-01 → 2023-09-30¥1.2bn
jpcrp040300-q2r_E00935-000Real Estatereportable segmentsegment profit2023-04-01 → 2023-09-30¥661m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥36.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥36.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥5.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 490
ItemContextValueUnit
Non operating incomePrior1YTDDuration277000000JPY
Non operating incomeCurrentYTDDuration341000000JPY
Interest expenses noePrior1YTDDuration8000000JPY
Interest expenses noeCurrentYTDDuration12000000JPY
Foreign exchange losses noePrior1YTDDuration54000000JPY
Foreign exchange losses noeCurrentYTDDuration54000000JPY
Other noePrior1YTDDuration5000000JPY
Other noeCurrentYTDDuration31000000JPY
Non operating expensesPrior1YTDDuration67000000JPY
Non operating expensesCurrentYTDDuration97000000JPY
Ordinary incomePrior1YTDDuration5722000000JPY
Ordinary incomeCurrentYTDDuration19823000000JPY
Gain on sales of investment securities eiPrior1YTDDuration4000000JPY
Gain on sales of investment securities eiCurrentYTDDuration－JPY
Other eiPrior1YTDDuration0JPY
Other eiCurrentYTDDuration0JPY
Extraordinary incomePrior1YTDDuration5000000JPY
Extraordinary incomeCurrentYTDDuration0JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration69000000JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration41000000JPY
Loss on valuation of investment securities elPrior1YTDDuration－JPY
Loss on valuation of investment securities elCurrentYTDDuration546000000JPY
Other elPrior1YTDDuration0JPY
Other elCurrentYTDDuration0JPY
Extraordinary lossPrior1YTDDuration69000000JPY
Extraordinary lossCurrentYTDDuration588000000JPY
Income before income taxesPrior1YTDDuration5658000000JPY
Income before income taxesCurrentYTDDuration19235000000JPY
Income taxesPrior1YTDDuration1590000000JPY
Income taxesCurrentYTDDuration4949000000JPY
Profit lossPrior1YTDDuration4068000000JPY
Profit lossCurrentYTDDuration14286000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration4068000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration14286000000JPY
Profit lossPrior1YTDDuration4068000000JPY
Profit lossCurrentYTDDuration14286000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration1748000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration-775000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration-2000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration-40000000JPY
Other comprehensive incomePrior1YTDDuration1745000000JPY
Other comprehensive incomeCurrentYTDDuration-816000000JPY
Comprehensive incomePrior1YTDDuration5814000000JPY
Comprehensive incomeCurrentYTDDuration13469000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration5814000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration13469000000JPY
Income before income taxesPrior1YTDDuration5658000000JPY
Income before income taxesCurrentYTDDuration19235000000JPY
Depreciation and amortization ope cfPrior1YTDDuration1291000000JPY
Depreciation and amortization ope cfCurrentYTDDuration1265000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-03-31pass
balance sheet identityconsolidated 2024-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass